Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-induced haemolytic anemia.

L D Petz, G Garratty

    Clinics in Haematology
    |February 1, 1975
    PubMed
    Summary

    Drug-induced immune hemolytic anemia affects 16-18% of cases. Different drugs trigger variable immune responses, impacting red blood cells and leading to diverse clinical and diagnostic outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology: Cancun report (2012).

    Vox sanguinis·2013
    Same author

    What do we mean by "Hyperhaemolysis" and what is the cause?

    Transfusion medicine (Oxford, England)·2012
    Same author

    International Society of Blood Transfusion Working Party on red cell immunogenetics and blood group terminology: Berlin report.

    Vox sanguinis·2011
    Same author

    Haemolytic anaemia and renal failure associated with antibodies to trimethoprim and sulfamethoxazole.

    Transfusion medicine (Oxford, England)·2010
    Same author

    Clinical evaluation for lymphoproliferative disease prompted by finding of IgM warm autoanti-IT in two cases.

    Immunohematology·2009
    Same author

    Neurologic abnormalities in HTLV-I- and HTLV-II-infected individuals without overt myelopathy.

    Neurology·2009

    Area of Science:

    • Hematology
    • Clinical Immunology
    • Pharmacology

    Background:

    • Drug administration is linked to 16-18% of acquired immune hemolytic anemia cases.
    • The mechanisms of drug-induced red blood cell sensitization vary significantly.
    • Understanding these mechanisms is crucial for accurate diagnosis and treatment.

    Purpose of the Study:

    • To elucidate the variable pathogenesis of drug-induced erythrocyte sensitization.
    • To explore the relationship between drugs, sensitization mechanisms, clinical signs, and diagnostic methods.
    • To differentiate drug-induced immune hemolytic anemia from other causes.

    Main Methods:

    • Review of drug-related antibody formation and complement fixation.
    • Analysis of drug interactions with red blood cells (e.g., immune complex formation, direct coating).
    • Correlation of clinical manifestations with laboratory diagnostic findings.

    Main Results:

    • Certain drugs (phenacetin, quinidine) form immune complexes causing intravascular hemolysis.
    • High-dose penicillins can coat red cells, leading to extravascular hemolysis.
    • Cephalosporins and alpha-methyldopa induce positive direct antiglobulin tests or autoimmune hemolytic anemia, respectively.
    • Non-immune mechanisms, like oxidative denaturation of hemoglobin, also cause drug-induced hemolytic anemia.

    Conclusions:

    • Drug-induced immune hemolytic anemia involves diverse mechanisms dependent on the specific drug.
    • Clinical presentation and laboratory findings are key to distinguishing drug-induced cases.
    • Knowledge of drug actions is essential for diagnosing and managing hemolytic anemias.

    Related Experiment Videos